Southern Research

04/30/2026

If you're connected to a middle or high school student in the Birmingham area, this one's worth sharing.

Southern Research's STEM program offers hands-on science experiences for K-12 students across Alabama, and summer camp spots are filling fast. From "Break into Biotech" for middle schoolers to "Biotech Academy" and "BioScholars Institute" for high schoolers, students work in real labs, explore biomedical science, and get a genuine look at what a career in STEM can look like.

All programs are held at Southern Research's STEM Outreach Center, located inside our newly built research facility in Birmingham. Scholarships are available.

Learn more and register: southernresearch.org/stem

03/11/2026

The SMART Antiviral Prize Concept Stage deadline is nearing.

Reviewers expect clear, fit-for-purpose data — not generic screening packages.

Southern Research combines validated biochemical and cell-based assays with chemistry and PK support to create decision-grade results that align with BARDA expectations.

You retain your IP. No reach-through.

Let’s outline a focused ex*****on plan for your submission. Contact us: https://southernresearch.org/contact/

03/04/2026

It is great to be at , in London with the team and our partners, Pathogenus.
Conversations here keep reminding us why this work matters — sponsors are sitting on powerful data, and the gap between that insight and actual clinical proof points is where we live. Whether it's infectious disease models, efficacy studies, or PK evaluation, that's the work we're here to support.
If you're around today, be sure to find us — always happy to talk science (or say hello).

03/02/2026

At AACR-IO, Dr. Rebecca Boohaker outlines her poster that explores the overlap between macrophage biology and checkpoint inhibition:
“Macrophage Reprogramming and Immune Checkpoint Blockade Efficacy in the Lewis Lung Carcinoma Model: Utility of Longitudinal CD206-Targeted Molecular Imaging.”

This work enables real-time identification of immune modulation via CD206-targeted molecular imaging, provides new insights into therapeutic response prediction, and reinforces our focus on advancing immuno-oncology models that generate actionable insights.

02/02/2026

Southern Research has formed a strategic partnership with UK-based Pathogenus—marking a significant step in expanding international collaborations and business development efforts.

This relationship strengthens our global presence and creates new opportunities to support clients and partners. It reflects our commitment to growing international impact through aligned missions and complementary expertise.

Read the full announcement:

Southern Research has entered a three-year global partnership with UK-based Pathogenus Consulting to expand international research collaborations and accelerate work on emerging and re-emerging diseases. The collaboration combines Southern Research’s BSL-2 and BSL-3 laboratory infrastructure with ...

12/23/2025

As we close out the year, we’re thankful for the partnerships and shared purpose that define Southern Research.

Our work moves forward through collaboration. With dedicated teams. With trusted partners. With organizations and communities committed to advancing science together.

What we achieve is the result of working side by side to turn research into innovation and impact.

Wishing you happy holidays and a year ahead filled with progress and possibility.

12/09/2025

Clinical evidence drives progress in health and medicine, yet many communities remain underrepresented in research. As a CRO dedicated to closing that gap, we are proud to have launched Catalyst by Southern Research, a multi-omic program that provides free, clinical-grade genetic testing and personalized guidance to Alabama adults.

Mallie’s story shows how this access can help an individual understand their hereditary risks and chart a more informed path forward:

Meet Mallie, a Birmingham local, who heard about Catalyst by Southern Research's free genetic testing through a friend and wanted to give it a try. She was a...

11/17/2025

We are on the ground at the American College of Toxicology's 46th Annual Meeting in Phoenix, Arizona, connecting with fellow professionals focused on advancing toxicology and preclinical development.

Say hello to our business development team on-site:
• Bill Coode, Sr. Business Development Executive
• Joseph Whittington, Business Development Executive
• Amir Rafie, Sr. Business Development Executive

They're ready to discuss how we support programs from discovery through IND-enabling studies.

10/21/2025

We are enjoying meaningful conversations and new connections here at ESWI 2025 in Spain.

Our team members—Fusataka Koide and Liesbeth Dekking—are on site and ready to talk about how Southern Research supports global infectious disease initiatives.

10/20/2025

We are proud to attend ESWI 2025 this week in Spain, joining global experts focused on the prevention and treatment of influenza, RSV, and other respiratory viruses.

Representing our team are Fusataka Koide, Senior Director of Global Client Engagement, and Liesbeth Dekking, our EU agent, both dedicated to advancing collaborative efforts in infectious disease research.

If you're attending, we’d love to connect.

10/02/2025

Southern Research is in Boston next week for the APA Annual Meeting, hosted by the Boston Society.

Joining the event are William (Bill) Coode, bringing expertise in strategic partnerships, and Dr. Paige Vinson, who leads our high-throughput screening initiatives to accelerate discovery.

We’re looking forward to insightful discussions and building meaningful connections.

09/30/2025

Today in Taipei, Southern Research is contributing to an important dialogue at the LBI Seminar on Cutting Edge Technologies for New Drug Development.

Our Sr. Director of Global Client Engagement, Fusataka Koide, is presenting insights on “Vaccine Development for Emerging and Re-emerging Viruses – Pre-Clinical Efficacy Models Employed at Southern Research.”

It’s part of our ongoing mission to support global partners with tools and science that help accelerate new treatments and protect public health.